https://www.sirius-medical.com/knowledge/breast-biopsy-needle-techniques

Core keyword: What does biopsy mean?

In the context of modern medicine, the meaning of biopsy has evolved from a purely histological diagnostic term to a bridge connecting macroscopic pathology and the microscopic molecular world. With the advent of the era of precision medicine, what biopsy provides is not just a few pieces of tissue, but rather a "password book" that opens the door to personalized treatment. And all of this is achieved without the need for what you described, namely modern breast biopsy needles made of specific materials and with specific specifications. These needles can efficiently and safely obtain high-quality samples to meet the increasingly complex requirements of genetic and molecular biological analyses.

Traditional pathological diagnosis mainly relies on observing the morphology and arrangement of cells under a microscope to determine their benign or malignant nature. Today, the connotation of biopsy has been greatly expanded. From the same biopsy sample, we can extract DNA and RNA and conduct a series of in-depth molecular tests. For example, by detecting whether there are mutations in genetic susceptibility genes such as BRCA1/2 in the sample, it can help assess the cancer risk of the patient themselves and their family members, and guide the selection of preventive surgeries or enhanced screening strategies.

More importantly, for patients with confirmed breast cancer, biopsy samples are the cornerstone for implementing precise treatment. What does biopsy mean? At the treatment decision-making level, it is through molecular pathology analysis to create a "molecular portrait" of each patient's tumor. We will test the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the Ki-67 proliferation index in the samples. These indicators determine whether the patient is suitable for endocrine therapy, anti-HER2 targeted therapy (such as trastuzumab, pertuzumab), and the intensity of the chemotherapy regimen.

Furthermore, with the widespread adoption of high-throughput sequencing technology, we can even conduct panel sequencing of hundreds of cancer-related genes on biopsy samples, searching for key gene mutations that drive the occurrence and development of tumors. For instance, the discovery of PIK3CA mutations may indicate that the patient is sensitive to certain PI3K inhibitors, while the appearance of ESR1 mutations may suggest that the patient has developed resistance to conventional endocrine therapy. These pieces of information are crucial for formulating precise treatment plans for the second and third lines of treatment.

What does biopsy mean? At the forefront of research and clinical translation, it is also reflected in the monitoring of tumor heterogeneity and dynamic changes. Different regions within the same tumor may have different gene mutations. Through multi-point biopsy, a more comprehensive understanding of the "full picture" of the tumor can be achieved. Moreover, for patients with recurrence or metastasis, a second biopsy of the metastatic site can reveal new drug-resistant mutations, guiding the adjustment of treatment plans. Although liquid biopsy (such as circulating tumor DNA testing) is non-invasive, tissue biopsy remains the "gold standard" for obtaining the most comprehensive and reliable molecular information.

Therefore, the value of modern breast biopsy needles lies not only in their physical properties (such as the hardness of stainless steel, the MRI compatibility of titanium alloys, and the sampling volume of specific gauge), but also in the high-quality "raw materials" they provide for downstream genetic and molecular analysis. Each meticulously designed biopsy needle is a solid bridge leading to the world of precision medicine. When we talk about what biopsy means, we are actually discussing how to utilize these precise tools to unlock massive molecular information and ultimately achieve "tailored" treatment for each breast cancer patient.